Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model
about
Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells.Proteasome inhibition suppresses essential immune functions of human CD4+ T cells.Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.Proteasome inhibition alleviates prolonged moderate compression-induced muscle pathologyRecent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.Proteasome inhibitor bortezomib suppresses nuclear factor-kappa B activation and ameliorates eye inflammation in experimental autoimmune uveitisInhibition of Proteasome Activity by Low-dose Bortezomib Attenuates Angiotensin II-induced Abdominal Aortic Aneurysm in Apo E(-/-) Mice.Inhibitors of selectin functions in the treatment of inflammatory skin disorders.Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner.Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.Humanized mice: are we there yet?Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrin.
P2860
Q33262643-559F53DA-901C-4D59-B568-76F564E95DA3Q33316357-46D28BB7-6C61-4D8B-A3E1-B7AC16D4C6BCQ33589167-4DE1A791-81B2-49AF-815C-DA8F3BE0BCA3Q33840106-A363DB05-B9E2-4651-B53B-3882F81333E3Q34327203-B58C1205-D824-443F-8800-D16809C0EDEDQ35012949-DC577BF9-4112-4ABE-AB61-724DB136C461Q36217025-6FE2928C-6332-4B76-808A-544F3B9AE696Q37116804-90FD1164-5C72-4175-BE6B-DBE85CDA6C6FQ37423197-6877DF55-85E4-4EB1-A0FC-7A00620652A1Q39971262-81A3447E-E479-4E9E-B627-F5CF69D49EF9Q42972285-315B7BB3-5E9B-4187-AA8D-DFFA0A3CCE68Q43279071-360E63AE-4561-41C7-B7EF-32C4E3F9F664
P2860
Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Proteasome inhibition reduces ...... f psoriasis in a SCID-hu model
@ast
Proteasome inhibition reduces ...... f psoriasis in a SCID-hu model
@en
Proteasome inhibition reduces ...... f psoriasis in a SCID-hu model
@nl
type
label
Proteasome inhibition reduces ...... f psoriasis in a SCID-hu model
@ast
Proteasome inhibition reduces ...... f psoriasis in a SCID-hu model
@en
Proteasome inhibition reduces ...... f psoriasis in a SCID-hu model
@nl
prefLabel
Proteasome inhibition reduces ...... f psoriasis in a SCID-hu model
@ast
Proteasome inhibition reduces ...... f psoriasis in a SCID-hu model
@en
Proteasome inhibition reduces ...... f psoriasis in a SCID-hu model
@nl
P2093
P2860
P356
P1476
Proteasome inhibition reduces ...... f psoriasis in a SCID-hu model
@en
P2093
Christine Pien
Maurizio Podda
Peter J Elliott
Roland Kaufmann
Thomas M Zollner
Wolf-Henning Boehncke
P2860
P356
10.1172/JCI12736
P407
P577
2002-03-01T00:00:00Z